Intellipharmaceutics International is a Canadian pharmaceutical company specializing in the development and commercialization of generic and innovative drugs, particularly in the area of sophisticated drug formulations. The company is known for its technology in the production of extended-release and targeted-release medications, which enhances the effectiveness and safety of drugs. Intellipharmaceutics focuses on areas such as cardiovascular diseases, neuroscience, and metabolic disorders. The company has global ambitions and seeks to enter into licensing and distribution agreements with pharmaceutical firms across various markets.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
